Mesa Laboratories
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $62,840 | $57,833 | $58,170 | $58,904 |
Gross Profit | 39,754 | 35,455 | 33,835 | 31,078 |
EBITDA | 6,122 | 12,898 | 11,823 | -267,149 |
EBIT | 625 | 6,830 | 6,358 | -273,444 |
Net Income | -1,676 | 3,428 | 3,388 | -254,583 |
Net Change In Cash | 62,840 | 57,833 | 58,170 | 58,904 |
Free Cash Flow | 17,626 | 3,483 | 9,542 | 12,348 |
Cash | 30,956 | 24,337 | 28,472 | 28,214 |
Basic Shares | 5,429 | 5,471 | 5,424 | 5,394 |
Annual Financials
| Values in thousands | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|
Revenue | $216,187 | $219,080 | $184,335 | $133,937 |
Gross Profit | 133,250 | 133,693 | 109,090 | 87,014 |
EBITDA | -238,376 | 36,454 | 29,770 | 12,358 |
EBIT | -269,950 | 3,320 | 4,702 | -5,114 |
Net Income | -254,246 | 930 | 1,871 | 3,274 |
Net Change In Cash | 216,187 | 219,080 | 184,335 | 133,937 |
Cost of Revenue | -14,839 | 181,309 | ||
Free Cash Flow | 41,566 | 23,439 | 34,791 | 35,081 |
Cash | 28,214 | 32,910 | 49,346 | 263,865 |
Basic Shares | 5,386 | 5,361 | 5,335 | 5,124 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.79 |
2024-09-30 | $0.63 |
2024-06-30 | $0.84 |
2024-03-31 | $3.70 |
